Recent Insights into the Functions of the Retinoblastoma Susceptibility Gene Product
- 1 January 1997
- journal article
- other
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (3), 243-254
- https://doi.org/10.3109/07357909709039722
Abstract
The retinoblastoma susceptibility gene (RB-1) was among the first tumor suppressor genes to be cloned and has provided many useful paradigms for the study of molecular alterations in cancer cells. This article will review recent insights into the role of its protein product, pRB, in cell growth control.This publication has 153 references indexed in Scilit:
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- The Retinoblastoma Protein Region Required for Interaction with the E2F Transcription Factor Includes the T/E1A Binding and Carboxy-Terminal SequencesDNA and Cell Biology, 1992
- Effects of an Rb mutation in the mouseNature, 1992
- Retinoblastoma protein switches the E2F site from positive to negative elementNature, 1992
- A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene productNature, 1991
- The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large TCell, 1990
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationCell, 1989
- Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcomaNature, 1989
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971